Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;111:1471-1479
Published online before print March 21, 2005, doi: 10.1161/01.CIR.0000159263.50305.BD
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
111/12/1471    most recent
01.CIR.0000159263.50305.BDv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guerra, R.
Right arrow Articles by Hobbs, H. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guerra, R.
Right arrow Articles by Hobbs, H. H.
Related Collections
Right arrow Lipids
Right arrow Risk Factors
Right arrow Chronic ischemic heart disease
Right arrow Epidemiology
Right arrow Lipid and lipoprotein metabolism

(Circulation. 2005;111:1471-1479.)
© 2005 American Heart Association, Inc.


Epidemiology

Lipoprotein(a) and Apolipoprotein(a) Isoforms

No Association With Coronary Artery Calcification in The Dallas Heart Study

Rudy Guerra, PhD; Zhaoxia Yu, MA; Santica Marcovina, PhD; Ronald Peshock, MD; Jonathan C. Cohen, PhD; Helen H. Hobbs, MD

From the Donald W. Reynolds Center for Clinical Cardiovascular Research (R.G., Z.Y., R.P., J.C.C., H.H.H.), Dallas, Tex; Department of Statistics (R.G., Z.Y.), Rice University, Houston, Tex; Department of Medicine (S.M.), University of Washington, Seattle, Wash; and Howard Hughes Medical Institute (H.H.H.) at the University of Texas Southwestern Medical Center, Dallas, Tex.

Correspondence to Helen H. Hobbs, Department of Molecular Genetics, UT Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390-9046. E-mail helen.hobbs{at}utsouthwestern.edu

Received June 22, 2004; revision received December 21, 2004; accepted December 29, 2004.

Background— Elevated plasma levels of lipoprotein(a) [Lp(a)] are an independent risk factor for cardiovascular disease in whites. Blacks have 2- to 3-fold higher plasma levels of Lp(a) than whites and yet do not have a correspondingly higher rate of coronary events. It remains unclear whether elevated plasma levels of Lp(a) are an independent risk factor for coronary atherosclerosis in individuals of African descent.

Methods and Results— The relationship between plasma levels of Lp(a), apolipoprotein(a) isoform sizes, and the presence of coronary calcium was examined in 761 blacks and 527 whites (men aged >40 years, women aged >45 years) from a population-based sample. No relationship was found between plasma levels of Lp(a), apolipoprotein(a) isoform size, or a combination of these 2 variables and coronary artery calcium (CAC) in whites or blacks. No correlation was observed between plasma levels of Lp(a) and coronary calcium scores in any group, although all black men with very high plasma levels of Lp(a) (>300 µmol/L; n=7) were CAC-positive. Whites with high plasma levels of Lp(a) plus elevated plasma levels of LDL cholesterol (men) or reduced levels of HDL cholesterol (men and women) or who smoked (women) had a higher prevalence of CAC. In contrast, no joint effects between plasma levels of Lp(a) and other cardiovascular risk factors on coronary calcium were found in blacks.

Conclusions— No consistent independent relationship between plasma levels of Lp(a) or apolipoprotein(a) isoform size and coronary calcium was found in whites or blacks.


Key Words: lipoproteins • apolipoproteins • arteriosclerosis • coronary disease • risk factors




This article has been cited by other articles:


Home page
CirculationHome page
S. Tsimikas, P. Clopton, E. S. Brilakis, S. M. Marcovina, A. Khera, E. R. Miller, J. A. de Lemos, and J. L. Witztum
Relationship of Oxidized Phospholipids on Apolipoprotein B-100 Particles to Race/Ethnicity, Apolipoprotein(a) Isoform Size, and Cardiovascular Risk Factors: Results From the Dallas Heart Study
Circulation, April 7, 2009; 119(13): 1711 - 1719.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
J. Suk Danik, N. Rifai, J. E. Buring, and P. M Ridker
Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women.
JAMA, September 20, 2006; 296(11): 1363 - 1370.
[Abstract] [Full Text] [PDF]